{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:12:46Z","timestamp":1792271566210,"version":"4.4.0"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00218","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:22:00Z","timestamp":1583313720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":177,"title":["Targeting of Hepatic Macrophages by Therapeutic Nanoparticles"],"prefix":"10.3389","volume":"11","author":[{"given":"Clara I.","family":"Colino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Lanao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gutierrez-Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J Control Release"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.5772\/67673","article-title":"The biological function of kupffer cells in liver disease","volume-title":"Biology of Myelomonocytic Cells","author":"Ma","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-2007-1007278","article-title":"Targeting of drugs to the liver","volume":"15","author":"Meijer","year":"1995","journal-title":"Semin Liver Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of Kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fimmu.2015.00328","article-title":"From the reticuloendothelial to mononuclear phagocyte system\u2014the unaccounted years","volume":"6","author":"Yona","year":"2015","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.it.2018.11.007","article-title":"The mononuclear phagocyte system: the relationship between monocytes and macrophages","volume":"40","author":"Hume","year":"2019","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-417028-5.00003-X","article-title":"A close encounter of the third kind: monocyte-derived cells","volume":"120","author":"Mildner","year":"2013","journal-title":"Adv Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1146\/annurev-immunol-032414-112220","article-title":"Macrophages: development and tissue specialization","volume":"33","author":"Varol","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1182\/blood-2009-07-235028","article-title":"Comparison of gene expression profiles between human and mouse monocyte subsets","volume":"115","author":"Ingersoll","year":"2010","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1182\/blood-2013-02-484188","article-title":"Transcription and enhancer profiling in human monocyte subsets","volume":"123","author":"Schmidl","year":"2014","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1182\/blood-2012-06-436212","article-title":"Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences","volume":"121","author":"Martinez","year":"2013","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cphy.c120026","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr Physiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1182\/blood-2007-02-073841","article-title":"Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages","volume":"110","author":"Klein","year":"2007","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4049\/jimmunol.1400574","article-title":"Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury","volume":"193","author":"Zigmond","year":"2014","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10321","DOI":"10.1038\/ncomms10321","article-title":"Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells","volume":"7","author":"Scott","year":"2016","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cell.2016.03.009","article-title":"A reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.ajpath.2016.06.003","article-title":"Pathogenesis of Kupffer cells in cholestatic liver injury","volume":"186","author":"Sato","year":"2016","journal-title":"Am J Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tips.2018.03.001","article-title":"Macrophage-targeted therapeutics for metabolic disease","volume":"39","author":"Peterson","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cellimm.2017.12.007","article-title":"Dynamic plasticity of macrophage functions in diseased liver","volume":"330","author":"Ritz","year":"2018","journal-title":"Cell Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"B24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"Obstfeld","year":"2010","journal-title":"Diabetes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2016.12.032","article-title":"Nanomedicines for dysfunctional macrophage-associated diseases","volume":"247","author":"He","year":"2017","journal-title":"J Control Release"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acsnano.6b06245","article-title":"Phenotype determines nanoparticle uptake by human macrophages from liver and blood","volume":"11","author":"MacParland","year":"2017","journal-title":"ACS Nano"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J Hepatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.nantod.2010.06.007","article-title":"Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases","volume":"5","author":"Li","year":"2010","journal-title":"Nano Today"},{"key":"B32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.biomaterials.2011.01.021","article-title":"The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles","volume":"32","author":"Xiao","year":"2011","journal-title":"Biomaterials"},{"key":"B34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.devcel.2004.09.009","article-title":"Caveolae meet endosomes: a stable relationship?","volume":"7","author":"Parton","year":"2004","journal-title":"Dev Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cell.2004.09.003","article-title":"Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic","volume":"118","author":"Pelkmans","year":"2004","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","author":"Gratton","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","article-title":"Nanoparticles in cellular drug delivery","volume":"17","author":"Faraji","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejpb.2010.11.010","article-title":"Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages","volume":"77","author":"Arnida","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"J Control Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"B43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijpharm.2007.07.038","article-title":"PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution","volume":"349","author":"Esmaeili","year":"2008","journal-title":"Int J Pharm"},{"key":"B44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejpb.2018.11.018","article-title":"Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis","volume":"134","author":"Hassan","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"B45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Reports"},{"key":"B46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.colsurfb.2017.07.014","article-title":"Contribution of Kupffer cells to liposome accumulation in the liver","volume":"158","author":"Samuelsson","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome((R))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/jac\/dks212","article-title":"Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model","volume":"67","author":"Sande","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1084\/jem.2016033411032016c","article-title":"Correction: identification and treatment of the Staphylococcus aureus reservoir in vivo","volume":"213","author":"Surewaard","year":"2016","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.biomaterials.2014.10.030","article-title":"Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases","volume":"37","author":"Bartneck","year":"2015","journal-title":"Biomaterials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.metabol.2017.09.002","article-title":"Immunomodulatory liposomes targeting liver macrophages arrest progression of non-alcoholic steatohepatitis","volume":"78","author":"Maradana","year":"2018","journal-title":"Metabolism"},{"key":"B52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.msec.2017.05.032","article-title":"Physicochemical properties of liposomal modifiers that shift macrophage phenotype","volume":"79","author":"Bygd","year":"2017","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"B53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0168-3659(02)00006-8","article-title":"Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers","volume":"80","author":"Opanasopit","year":"2002","journal-title":"J Control Release"},{"key":"B54","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2015.12.014","article-title":"Drug delivery to macrophages: challenges and opportunities","volume":"240","author":"Pei","year":"2016","journal-title":"J Control Release"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"Torrado","year":"2008","journal-title":"J Pharm Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biomaterials.2019.03.025","article-title":"Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo","volume":"206","author":"Ergen","year":"2019","journal-title":"Biomaterials"},{"key":"B57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejps.2018.07.036","article-title":"Synthesis of high functionality and quality mannose-grafted lipids to produce macrophage-targeted liposomes","volume":"123","author":"Hagimori","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1038\/mtna.2012.63","article-title":"Lipidoid nanoparticles containing PD-L1 siRNA delivered in vivo enter Kupffer cells and enhance NK and CD8(+) T cell-mediated hepatic antiviral immunity","volume":"2","author":"Dolina","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"B61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biomaterials.2015.04.025","article-title":"Inhibition of MAP kinase\/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles","volume":"59","author":"Selvaraj","year":"2015","journal-title":"Biomaterials"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.06.008","article-title":"Spherical neutral gold nanoparticles improve anti-inflammatory response, oxidative stress and fibrosis in alcohol-methamphetamine-induced liver injury in rats","volume":"548","author":"de Carvalho","year":"2018","journal-title":"Int J Pharm"},{"key":"B63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.06.015","article-title":"Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors","volume":"178","author":"Gan","year":"2018","journal-title":"Biomaterials"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.nano.2015.11.020","article-title":"Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion","volume":"12","author":"Rojas","year":"2016","journal-title":"Nanomedicine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bcp.2018.12.003","article-title":"Effects of inorganic nanoparticles on liver fibrosis: optimizing a double-edged sword for therapeutics","volume":"160","author":"Tee","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcp.2017.09.003","article-title":"Therapeutic potential of carbohydrates as regulators of macrophage activation","volume":"146","author":"Lundahl","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.actbio.2017.09.037","article-title":"Delivery of the TLR ligand poly(I:C) to liver cells in vitro and in vivo by calcium phosphate nanoparticles leads to a pronounced immunostimulation","volume":"64","author":"Sokolova","year":"2017","journal-title":"Acta Biomater"},{"key":"B68","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.biomaterials.2015.02.068","article-title":"Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics","volume":"52","author":"Mulens-Arias","year":"2015","journal-title":"Biomaterials"},{"key":"B69","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbrc.2013.10.115","article-title":"SPION primes THP1 derived M2 macrophages toward M1-like macrophages","volume":"441","author":"Laskar","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1021\/nn402145t","article-title":"Dysregulation of macrophage activation profiles by engineered nanoparticles","volume":"7","author":"Kodali","year":"2013","journal-title":"ACS Nano"},{"key":"B71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biomaterials.2019.02.026","article-title":"Iron oxide nanoparticles promote macrophage autophagy and inflammatory response through activation of toll-like Receptor-4 signaling","volume":"203","author":"Jin","year":"2019","journal-title":"Biomaterials"},{"key":"B72","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumor growth by inducing pro-inflammatory macrophage polarization in tumor tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat Nanotechnol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI44490","article-title":"An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice","volume":"121","author":"Sindrilaru","year":"2011","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.biomaterials.2010.08.111","article-title":"Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages","volume":"32","author":"Lunov","year":"2011","journal-title":"Biomaterials"},{"key":"B75","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jcyt.2017.01.003","article-title":"Functionalized superparamagnetic iron oxide nanoparticles provide highly efficient iron-labeling in macrophages for magnetic resonance-based detection in vivo","volume":"19","author":"Sharkey","year":"2017","journal-title":"Cytotherapy"},{"key":"B76","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.apmt.2018.12.006","article-title":"Tracking stem cells and macrophages with gold and iron oxide nanoparticles \u2013 the choice of the best suited particles","volume":"15","author":"Sun","year":"2019","journal-title":"Appl Mater Today"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.nano.2016.01.013","article-title":"Cellular distribution of injected PLGA-nanoparticles in the liver","volume":"12","author":"Park","year":"2016","journal-title":"Nanomedicine"},{"key":"B78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jconrel.2018.09.004","article-title":"Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis","volume":"288","author":"Kurniawan","year":"2018","journal-title":"J Control Release"},{"key":"B79","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jconrel.2013.06.012","article-title":"Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity","volume":"170","author":"Di Mascolo","year":"2013","journal-title":"J Control Release"},{"key":"B80","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2019.04.044","article-title":"Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver","volume":"304","author":"Cui","year":"2019","journal-title":"J Control Release"},{"key":"B81","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.dld.2016.11.008","article-title":"CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice","volume":"49","author":"Canup","year":"2017","journal-title":"Dig Liver Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jcis.2016.11.088","article-title":"Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages","volume":"490","author":"Xiao","year":"2017","journal-title":"J Colloid Interface Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijbiomac.2019.02.036","article-title":"Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle","volume":"129","author":"Iranpur Mobarakeh","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.biomaterials.2015.02.044","article-title":"Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles","volume":"52","author":"Chu","year":"2015","journal-title":"Biomaterials"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1128\/AAC.04213-14","article-title":"Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation","volume":"59","author":"Jain","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1016\/j.biomaterials.2013.06.008","article-title":"Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-alpha RNA interference for IBD therapy","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials"},{"key":"B87","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unraveling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.nano.2013.05.003","article-title":"Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities, and biodistribution for reduction of human immunodeficiency virus infections","volume":"9","author":"Puligujja","year":"2013","journal-title":"Nanomedicine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages","volume":"508","author":"Jiang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/sctm.16-0226","article-title":"Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice","volume":"6","author":"Haga","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jconrel.2015.09.027","article-title":"Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals","volume":"217","author":"Bagalkot","year":"2015","journal-title":"J Control Release"},{"key":"B92","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.biomaterials.2015.02.070","article-title":"Macrophage silica nanoparticle response is phenotypically dependent","volume":"53","author":"Herd","year":"2015","journal-title":"Biomaterials"},{"key":"B93","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.lfs.2019.03.062","article-title":"Attributes of alternatively activated (M2) macrophages","volume":"224","author":"Shrivastava","year":"2019","journal-title":"Life Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrep.2019.01.007","article-title":"Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting","volume":"17","author":"Hatami","year":"2019","journal-title":"Biochem Biophys Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J Am Chem Soc"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.2147\/IJN.S208496","article-title":"Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels","volume":"14","author":"Jiang","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"B97","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.2147\/IJN.S142060","article-title":"Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport","volume":"12","author":"Jiang","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.toxrep.2018.05.004","article-title":"Short-term biodistribution and clearance of intravenously administered silica nanoparticles","volume":"5","author":"Waegeneers","year":"2018","journal-title":"Toxicol Rep"},{"key":"B99","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/15376516.2016.1169341","article-title":"Mast cell accumulation precedes tissue fibrosis induced by intravenously administered amorphous silica nanoparticles","volume":"26","author":"Zhuravskii","year":"2016","journal-title":"Toxicol Mech Methods"},{"key":"B100","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1212\/WNL.0b013e31829bfd8f","article-title":"Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL","volume":"81","author":"Farrell","year":"2013","journal-title":"Neurology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/jat.3323","article-title":"Biodistribution of polyacrylic acid-coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity","volume":"36","author":"Couto","year":"2016","journal-title":"J Appl Toxicol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.2147\/IJN.S192189","article-title":"Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars","volume":"14","author":"Liu","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1093\/nar\/gkw112","article-title":"Stabilin-1 and stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver","volume":"44","author":"Miller","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1021\/acsnano.7b06995","article-title":"Directing nanoparticle biodistribution through evasion and exploitation of stab2-dependent nanoparticle uptake","volume":"12","author":"Campbell","year":"2018","journal-title":"ACS Nano"},{"key":"B105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fimmu.2018.00103","article-title":"Macrophage recognition of crystals and nanoparticles","volume":"9","author":"Nakayama","year":"2018","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e103576","DOI":"10.1371\/journal.pone.0103576","article-title":"Quantitative evaluation of the reticuloendothelial system function with dynamic MRI","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"B107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yrtph.2015.06.019","article-title":"Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats","volume":"73","author":"Sweeney","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/17435390.2018.1459922","article-title":"Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling","volume":"12","author":"Cheng","year":"2018","journal-title":"Nanotoxicology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2165\/00003088-200948030-00004","article-title":"Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modeling","volume":"48","author":"Edginton","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.3390\/pharmaceutics11040179","article-title":"Biodistribution and physiologically-based pharmacokinetic modeling of gold nanoparticles in mice with interspecies extrapolation","volume":"11","author":"Aborig","year":"2019","journal-title":"Pharmaceutics"},{"key":"B111","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2147\/IJN.S94370","article-title":"Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles","volume":"11","author":"Carlander","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.xphs.2018.10.037","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"108","author":"Yuan","year":"2019","journal-title":"J Pharm Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1038\/psp.2013.41","article-title":"Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development","volume":"2","author":"Jones","year":"2013","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.apsb.2016.04.004","article-title":"PBPK modeling and simulation in drug research and development","volume":"6","author":"Zhuang","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"B115","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2165\/00003088-200847110-00005","article-title":"Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis","volume":"47","author":"Edginton","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"B116","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1021\/nn1018818","article-title":"Physiologically based pharmacokinetic modeling of nanoparticles","volume":"4","author":"Li","year":"2010","journal-title":"ACS Nano"},{"key":"B117","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumors","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.2147\/IJN.S46624","article-title":"A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles","volume":"8","author":"Bachler","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"B119","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.03.011","article-title":"Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death","volume":"146","author":"Epstein-Barash","year":"2010","journal-title":"J Control Release"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem Soc Rev"},{"key":"B122","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine"},{"key":"B123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.addr.2018.09.012","article-title":"Animal models for analysis of immunological responses to nanomaterials: challenges and considerations","author":"Zamboni","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"B124","doi-asserted-by":"publisher","first-page":"152344","DOI":"10.1016\/j.tox.2019.152344","article-title":"Influence of nanoparticles on liver tissue and hepatic functions: a review","volume":"430","author":"Cornu","year":"2020","journal-title":"Toxicology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.biomaterials.2009.11.079","article-title":"Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats","volume":"31","author":"Balasubramanian","year":"2010","journal-title":"Biomaterials"},{"key":"B126","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1517\/17425247.2011.554818","article-title":"Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems","volume":"8","author":"Karmali","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"B127","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J"},{"key":"B128","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.nano.2008.11.002","article-title":"Protracted elimination of gold nanoparticles from mouse liver","volume":"5","author":"Sadauskas","year":"2009","journal-title":"Nanomedicine"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.nano.2014.06.005","article-title":"Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration","volume":"10","author":"Fraga","year":"2014","journal-title":"Nanomedicine"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.2147\/IJN.S160995","article-title":"The protective role of quercetin and arginine on gold nanoparticles induced hepatotoxicity in rats","volume":"13","author":"Abdelhalim","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"B131","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.2147\/IJN.S132304","article-title":"Silica nanoparticles induce liver fibrosis via TGF-beta1\/Smad3 pathway in ICR mice","volume":"12","author":"Yu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B132","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.toxlet.2010.12.010","article-title":"Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis","volume":"201","author":"Piao","year":"2011","journal-title":"Toxicol Lett"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3109\/17435390.2016.1163743","article-title":"Acute systemic exposure to silver-based nanoparticles induces hepatotoxicity and NLRP3-dependent inflammation","volume":"10","author":"Ramadi","year":"2016","journal-title":"Nanotoxicology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/toxsci\/kfs306","article-title":"Effects of silver nanoparticles on the liver and hepatocytes in vitro","volume":"131","author":"Gaiser","year":"2013","journal-title":"Toxicol Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cbpc.2019.05.006","article-title":"The influence of titanium dioxide nanoparticles on their cellular response to macrophage cells","volume":"223","author":"Hu","year":"2019","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jconrel.2019.04.041","article-title":"Subchronic toxicity of silica nanoparticles as a function of size and porosity","volume":"304","author":"Mohammadpour","year":"2019","journal-title":"J Control Release"},{"key":"B137","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tiv.2016.09.022","article-title":"Impact of cerium oxide nanoparticles shape on their in vitro cellular toxicity","volume":"38","author":"Forest","year":"2017","journal-title":"Toxicol In Vitro"},{"key":"B138","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1016\/j.biomaterials.2010.03.048","article-title":"Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles","volume":"31","author":"Souris","year":"2010","journal-title":"Biomaterials"},{"key":"B139","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1042\/bj0320426","article-title":"The biochemistry of silicic acid: the solution and excretion of silica","volume":"32","author":"King","year":"1938","journal-title":"Biochem J"},{"key":"B140","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2012.05.046","article-title":"in vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity, and surface characteristics","volume":"163","author":"Yu","year":"2012","journal-title":"J Control Release"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/smll.200900923","article-title":"Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles","volume":"5","author":"He","year":"2009","journal-title":"Small"},{"key":"B142","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharep.2016.09.017","article-title":"Anti-inflammatory, analgesic and anti-tumor properties of gold nanoparticles","volume":"69","author":"de Araujo","year":"2017","journal-title":"Pharmacol Rep"},{"key":"B143","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.biomaterials.2015.10.004","article-title":"Gold conjugate-based liposomes with hybrid cluster bomb structure for liver cancer therapy","volume":"74","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"B144","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1016\/j.biomaterials.2010.03.023","article-title":"The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages","volume":"31","author":"Lunov","year":"2010","journal-title":"Biomaterials"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:22:03Z","timestamp":1583313723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2020.00218"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00218","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"article-number":"218"}}